Biomaterials have become increasingly important in biomedical devices and tissue engineering, aiming to restore normal bodily function by unlocking the regenerative potential of human tissues. Synthetic biomaterials mimic the complex, dynamic interactions of natural cellular environments, incorporating biologically active components to support stem cell growth and tissue regeneration. Advances in materials science, matrix biology, and tissue engineering have enhanced biomaterial sophistication, but clinical translation requires efficacy, safety, cost-effectiveness, and convenience. Human-derived biomaterials, such as decellularized ECM scaffolds and autologous preparations, offer new approaches for tissue repair and regeneration. These materials, including naturally occurring biomacromolecules and growth factors, can be tailored to target the body's repair capacity or create new tissues. The design of biomaterials aims to replicate the structural, mechanical, biochemical, and biological information of native tissues to guide tissue formation. Challenges include controlling degradation, mechanical properties, and cell-matrix interactions, as well as ensuring biocompatibility and clinical translation. Recent advances in biomimetic design, synthetic polymers, and 3D printing have improved scaffold fabrication, enabling precise control over structure and function. However, challenges remain in achieving optimal tissue regeneration, drug delivery, and commercial viability. The integration of natural and synthetic materials, along with advancements in drug delivery systems, is crucial for developing effective regenerative therapies. Future directions include optimizing biomaterials for clinical applications, enhancing biocompatibility, and addressing the complexities of tissue engineering and regenerative medicine.Biomaterials have become increasingly important in biomedical devices and tissue engineering, aiming to restore normal bodily function by unlocking the regenerative potential of human tissues. Synthetic biomaterials mimic the complex, dynamic interactions of natural cellular environments, incorporating biologically active components to support stem cell growth and tissue regeneration. Advances in materials science, matrix biology, and tissue engineering have enhanced biomaterial sophistication, but clinical translation requires efficacy, safety, cost-effectiveness, and convenience. Human-derived biomaterials, such as decellularized ECM scaffolds and autologous preparations, offer new approaches for tissue repair and regeneration. These materials, including naturally occurring biomacromolecules and growth factors, can be tailored to target the body's repair capacity or create new tissues. The design of biomaterials aims to replicate the structural, mechanical, biochemical, and biological information of native tissues to guide tissue formation. Challenges include controlling degradation, mechanical properties, and cell-matrix interactions, as well as ensuring biocompatibility and clinical translation. Recent advances in biomimetic design, synthetic polymers, and 3D printing have improved scaffold fabrication, enabling precise control over structure and function. However, challenges remain in achieving optimal tissue regeneration, drug delivery, and commercial viability. The integration of natural and synthetic materials, along with advancements in drug delivery systems, is crucial for developing effective regenerative therapies. Future directions include optimizing biomaterials for clinical applications, enhancing biocompatibility, and addressing the complexities of tissue engineering and regenerative medicine.